Yes, he can take both glipizide 10 mg and Ozempic (semaglutide) together, but the glipizide dose should be reduced by 50% immediately to prevent hypoglycemia.
Immediate Action Required
Reduce the glipizide dose from 10 mg to 5 mg daily when starting Ozempic 1, 2. This is critical because combining a GLP-1 receptor agonist like semaglutide with a sulfonylurea significantly increases hypoglycemia risk 2.
Why This Combination Makes Sense
With an A1c of 8.9%, this patient needs intensification of therapy. The 2025 ADA guidelines support adding a GLP-1 receptor agonist to existing therapy when A1c is >1.5% above target 3. Semaglutide offers:
- High glucose-lowering efficacy (expected A1c reduction of 1.0-1.5%) 3
- Cardiovascular benefit - reduces major adverse cardiovascular events 4, 3
- Kidney protection - slows eGFR decline and reduces albuminuria 4
- Weight loss - addresses a common comorbidity 3
For a 70-year-old, these cardiovascular and renal benefits are particularly valuable 4, 5.
Managing the Combination Safely
Hypoglycemia Prevention Strategy:
- Start with glipizide dose reduction to 5 mg when initiating Ozempic 1, 2
- Titrate Ozempic slowly: Begin at 0.25 mg weekly for 4 weeks, then increase to 0.5 mg weekly 2
- Intensify home glucose monitoring for the first 4 weeks 1, 2
- Educate the patient on hypoglycemia symptoms and management 2
- Consider discontinuing glipizide entirely once Ozempic reaches therapeutic dose (0.5-1.0 mg weekly), as semaglutide alone may provide adequate control 4, 3
Age-Specific Considerations:
At age 70, if this patient is otherwise healthy with intact cognitive function, an A1c target of 7.0-7.5% is appropriate 6, 7. The combination therapy should achieve this target while minimizing hypoglycemia risk, which is particularly important in older adults 6, 7.
Monitoring Plan:
- Check blood glucose 2-3 times daily during the first month, especially before meals and at bedtime
- Watch for hypoglycemia symptoms: confusion, dizziness, sweating, weakness - these may be blunted in older adults 6
- Recheck A1c in 3 months to assess response and determine if glipizide can be discontinued 5
- Monitor kidney function if not recently checked, as both medications require consideration of renal status 8, 4
Glipizide Dosing in Context
Glipizide is hepatically metabolized and can be used cautiously in older adults, but should be initiated at conservative doses (2.5 mg daily) 8. At 10 mg daily, this patient is on a moderate-to-high dose, making dose reduction even more critical when adding semaglutide.
Common Pitfall to Avoid
Do not continue glipizide at full dose when starting Ozempic. The FDA label for Ozempic explicitly warns about hypoglycemia risk when combined with insulin secretagogues like sulfonylureas 2. The 2018 ACC Expert Consensus recommends a 50% sulfonylurea dose reduction when initiating GLP-1 receptor agonists 1.
Alternative Approach
If hypoglycemia becomes problematic even with reduced glipizide, consider switching entirely to semaglutide monotherapy (with or without metformin if not contraindicated). GLP-1 receptor agonists have minimal hypoglycemia risk when used alone and may provide superior glycemic control compared to sulfonylureas 3, 9, 5.